ERBB2 and non-small cell lung carcinoma: Authors examined tumors from 1007 NSCLC patients for detection of KRAS, EGFR, ALK, HER2, BRAF, PIK3CA, MET, NRAS, MEK1, and AKT1 genes abnormalities.